A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.

NCT07543380 · clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
130
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer